H. Ishii

Publications502
h-index38
Citations5,595
Highly Influential Citations200
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • T. Okusaka
  • 657 Publications, 17,153 Citations
  • J. Furuse
  • 464 Publications, 10,399 Citations
  • M. Kudo
  • 1,242 Publications, 32,701 Citations
  • M. Ikeda
  • 516 Publications, 8,086 Citations
  • Publications
  • Influence
Characterization of degradation process of cyanobacterial hepatotoxins by a gram-negative aerobic bacterium.
A bacterium termed 7CY, capable of decomposing cyanobacterial toxins, was isolated from surface water sample of Lake Suwa and degradation of microcystin-RR and nodularin-Har was investigated. The… Expand
  • 156
  • 19
Temporal Changes in Cell Marker Expression and Cellular Infiltration in a Controlled Cortical Impact Model in Adult Male C57BL/6 Mice
Background Traumatic injury to the central nervous system (CNS) triggers a robust inflammatory response that leads to axonal damage and secondary degeneration of spared tissue. In contrast, some… Expand
  • 127
  • 11
  • PDF
Phase I study of sorafenib in Japanese patients with hepatocellular carcinoma
Sorafenib is an orally active multikinase inhibitor that targets serine and threonine, and tyrosine kinases that are involved in tumor‐cell signal transduction and tumor angiogenesis. This phase I… Expand
  • 168
  • 9
Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer
Purpose: This phase II study was conducted to evaluate the efficacy and toxicity of single-agent gemcitabine in patients with advanced or metastatic biliary tract cancer. Patients and methods:… Expand
  • 140
  • 5
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
Purpose: The carcinoembryonic antigen glypican-3 (GPC3) is an ideal target of anticancer immunotherapy against hepatocellular carcinoma (HCC). In this nonrandomized, open-label, phase I clinical… Expand
  • 196
  • 5
Incidence of dementia and associated risk factors in Japan: The Osaki-Tajiri Project
The incidence of dementia and risk factors has not been fully investigated in Japan. Following a prevalence study in 1998, we investigated the incidence and associated factors in the same population… Expand
  • 60
  • 5
  • PDF
Solitary Schwannoma of the Colon: Report of Two Cases
Abstract Some patients with gastrointestinal schwannoma (GIS) have been previously reported in the literature. However, GIS of the colon is quite rare. In addition, it is sometimes difficult to… Expand
  • 44
  • 5
Alveolar macrophage-epithelial cell interaction following exposure to atmospheric particles induces the release of mediators involved in monocyte mobilization and recruitment
BackgroundStudies from our laboratory have shown that human alveolar macrophages (AM) and bronchial epithelial cells (HBEC) exposed to ambient particles (PM10) in vitro increase their production of… Expand
  • 125
  • 4
Contribution of IL-1β and TNF-α to the initiation of the peripheral lung response to atmospheric particulates (PM10)
Alveolar macrophages (AM) play a key role in clearing atmospheric particulates from the lung surface and stimulating epithelial cells to produce proinflammatory mediators. The present study examine...
  • 92
  • 4
  • PDF
Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01…
PurposeTo evaluate the efficacy and safety of the combination of gemcitabine (GEM) and S-1 (GS) in comparison to GEM alone (G) for unresectable pancreatic cancer.MethodsIn this multicenter randomized… Expand
  • 66
  • 4